Fox Business - The Power to Prosper
Search Site

Hospira

Related Topics

  1. After Hours Trading
  2. Miles White
  3. Abbott Laboratories
  4. 3M
Get updates on Hospira
U.S. court ruling favors Cubist in patent case versus Hospira

A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc .The ruling, in U.S. District Court in Delaware, is a positive development for Cubist in the ongoing case, which is scheduled to go to trial in February 2014, said Cubist spokeswoman Julie DiCarlo. Cubicin, an antibiotic injection used in hospitals to treat bacterial skin infections, is the company's primary revenue driver."Today the court ruled in favor of Cubist on the interpretation of all disputed claim terms in our patent infringement case against Hospira," DiCarlo said.A Hospira spokesman declined to comment, citing a company policy of not discussing ongoing litigation.Cubist filed the patent infringement suit against Hospira in March 2012, in response to a Hospira filing with U.S. regulators indicating its intent to develop a generic version of Cubicin, DiCarlo said.Cubist has six patents f...

Read More ›

  1. Hospira Names John Staley Non-executive Chairman

    Hospira Inc. said late Wednesday it named John Staley its new non-executive chairman with the retirement of current chairman Christopher Begley. Staley, 70, will suc...

  2. Obama Orders FDA to Reduce Drug Shortages ?

    President Barack Obama signed an executive order Monday to address the shortage of prescription drug that the White House says leads to price gauging and puts patien...

  3. Hospira looks to M&A to penetrate emerging markets

    CHICAGO (Reuters) - Hospira Inc is seeking acquisitions that will help it penetrate emerging markets such as Brazil and China , its new chief executive said Wednesda...

  4. What the iPad Can Do for You

    The Wall Street Journal's Walt Mossberg breaks down the best that iPad 2 has to offer for the everyday consumer.

  5. Hospira Appoints Allergen's Mike Ball as CEO

    For the first time since its 2004 spin-off from Abbott Laboratories (NYSE:ABT), Hospira (NYSE:HSP) has named a new chief executive.Current Allergan (NYSE:AGN) presid...

  6. Hospira Will Indefinitely Halt Production of Lethal Injection Drug

    Hospira (NYSE:HSP), the sole maker of leading execution drug Pentothal, has decided to permanently stop producing the injectable drug, citing pressure from Italian a...

  7. Smiths Group Shares Soar After It Gets Approach

    LONDON -(Dow Jones)- Shares in U.K.-based technology company Smiths Group PLC (SMIN.LN) jumped over 10% Monday morning after it said late Friday it had rejected a ca...

  8. Hospira CEO Retiring, Searching for External Successor

    Hospira Inc. (NYSE:HSP) CEO Chris Begley is retiring from the chief spot, sending the company in search of a successor, its board of directors said Friday.Begley, wh...

  1. Health Care Sector Wrap

    The Health Care sector (XLV) showed little movement on a trading day that saw S&P 500 fall 0.7%.Repligen Corporation (NASDAQ:RGEN) was a significant gainer in the se...

  2. Hospira Shares Jump On Earnings News

    Shares of Hospira Inc. climbed more than 5% Wednesday morning after the maker of injectable drugs reported second-quarter earnings that beat analyst estimates. The c...

  3. Hospira Recalls Cancer Drugs Due to Glass Particles

    Hospira Inc said it has issued a nationwide recall of four of its injectable cancer drugs because of particles embedded in the glass at the neck of the vial.The drug...

  4. Royal Gold, Comcast Included in Stocks Up on High Volume Monday

    There are a few stocks that are up on high volume today:Royal Gold (NASDAQ:RGLD) was up on high volume today, after trading at a volume of 8.5 million, or 8.4 times ...

  5. WSJ BLOG/Health: FDA Approves New Suppliers for Scarce Cancer Drugs

    (This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)New supplies of two currently hard-to-find cancer drugs a...

  6. Hospira Shares Jump On Strong Earnings Report

    Hospira Inc. shares rose as much as 9% at the open Tuesday, making it the biggest percentage gainer in the S&P 500 Index. The move followed the release of the specia...

  7. Durect Plunges 33% On Failed Drug Study

    Shares of Durect Corp. plunged 33% to 79 cents on Friday, the day after it reported that a Phase III clinical trial failed to show its painkiller Posidur was effecti...

Freebase CC-BY
Source: Hospira on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL